Dr. Agarwal's Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.As of 15 Jun 2026, DR. AGARWAL'S EYE HOSP L share price is ₹4,975.00. The stock opened at ₹4,951.00, compared to its previous close of ₹4,895.60. During today's trading session, DR. AGARWAL'S EYE HOSP L share price moved in the range of ₹4,855.70 to ₹5,032.40, with an average price of ₹4,944.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,855.70 and a high of ₹5,032.40. On the performance front, DR. AGARWAL'S EYE HOSP L share price has declined by 0.99% over the last six months and is down 0.99% on a year-on-year basis.
The market capitalization of DR. AGARWAL'S EYE HOSP L is ₹2,398 Crs, with a P/E ratio of 34.2 and a dividend yield of 0.08%.